GYNIRIS ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  1.3% 1.2% 2.2% 1.3% 1.3%  
Credit score (0-100)  80 82 66 79 81  
Credit rating  A A BBB A A  
Credit limit (kDKK)  581.7 1,232.1 1.4 601.7 672.6  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  -218 -220 -210 -209 -116  
EBITDA  -338 -285 -381 -375 -288  
EBIT  -338 -285 -381 -375 -288  
Pre-tax profit (PTP)  3,132.4 4,481.9 -4,337.4 3,750.3 2,060.8  
Net earnings  2,441.9 3,488.3 -3,378.3 2,933.4 1,611.7  
Pre-tax profit without non-rec. items  3,132 4,482 -4,337 3,750 2,061  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  39,965 41,153 36,475 39,349 38,461  
Interest-bearing liabilities  700 869 1,528 226 996  
Balance sheet total (assets)  40,913 42,048 38,028 39,607 39,490  

Net Debt  -34,449 -34,919 -29,361 -33,228 -32,595  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -218 -220 -210 -209 -116  
Gross profit growth  -2.0% -0.9% 4.4% 0.5% 44.4%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  40,913 42,048 38,028 39,607 39,490  
Balance sheet change%  4.8% 2.8% -9.6% 4.2% -0.3%  
Added value  -338.3 -285.2 -381.1 -375.1 -288.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  155.4% 129.7% 181.4% 179.5% 248.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  8.0% 10.9% 2.7% 9.8% 5.3%  
ROI %  8.0% 10.9% 2.7% 9.8% 5.3%  
ROE %  6.3% 8.6% -8.7% 7.7% 4.1%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  97.7% 97.9% 95.9% 99.3% 97.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  10,181.7% 12,244.5% 7,704.6% 8,857.4% 11,314.0%  
Gearing %  1.8% 2.1% 4.2% 0.6% 2.6%  
Net interest  0 0 0 0 0  
Financing costs %  5.4% 3.6% 452.2% 5.6% 6.7%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  37.1 40.6 20.8 131.1 32.8  
Current Ratio  37.1 40.6 20.8 131.1 32.8  
Cash and cash equivalent  35,149.0 35,788.8 30,889.8 33,454.3 33,590.5  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -394.2 20.1 230.8 1,811.0 -33.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -338 -285 -381 -375 -288  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -338 -285 -381 -375 -288  
EBIT / employee  -338 -285 -381 -375 -288  
Net earnings / employee  2,442 3,488 -3,378 2,933 1,612